Paradigm Biopharmaceuticals Limit Reports Daily Gross Short Sales (Australia)

Australia, Jan. 7 -- Paradigm Biopharmaceuticals Limit (PAR) has reported gross short sales of 16,898 FPO shares on Jan. 3. The percent of issued capital of the company reported as short sales is 0.0 percent. The issued capital of the company is 389,303,603 shares.

Disclaimer: Curated by HT Syndication.